BCL6 and diffuse large B-cell lymphoma: In DLBCL cells, CK2α inhibition caused a reduction in the phosphorylation of AKT, FOXO, and p65/RelA, combined with decreased BCL6 expression (Figure 9B), similarly to what was observed in normal murine B cells (Figures 8B).